226 related articles for article (PubMed ID: 12218613)
1. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
Yetiser S; Satar B; Aydin N
Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
[TBL] [Abstract][Full Text] [Related]
2. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
[TBL] [Abstract][Full Text] [Related]
3. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis.
Kuczkowski J; Sakowicz-Burkiewicz M; Iżycka-Świeszewska E; Mikaszewski B; Pawełczyk T
ORL J Otorhinolaryngol Relat Spec; 2011; 73(2):93-9. PubMed ID: 21311206
[TBL] [Abstract][Full Text] [Related]
4. [The roles of interleukin-1 alpha, tumor necrosis factor-alpha and parathyroid hormone-related protein in bone resorption of cholesteatoma otitis].
Kinoshita K
Nihon Jibiinkoka Gakkai Kaiho; 1994 Aug; 97(8):1472-80. PubMed ID: 7931803
[TBL] [Abstract][Full Text] [Related]
5. Bone Damage in Chronic Otitis Media.
Kuczkowski J; Brzoznowski W; Nowicki T
Ear Nose Throat J; 2022 Aug; 101(7):428-429. PubMed ID: 33090898
[TBL] [Abstract][Full Text] [Related]
6. Osteoclastic activity in chronic otitis media with cholesteatoma-related bone destruction.
Özgür A; Yemiş T; Başbulut E; Turgut NF; Özdemir D; Akgül G; Mehel DM; Çelebi M
J Laryngol Otol; 2021 Oct; 135(10):879-882. PubMed ID: 34348812
[TBL] [Abstract][Full Text] [Related]
7. Activation of NLRP3 inflammasome in human middle ear cholesteatoma and chronic otitis media.
Kariya S; Okano M; Zhao P; Kataoka Y; Yoshinobu J; Maeda Y; Ishihara H; Higaki T; Nishizaki K
Acta Otolaryngol; 2016; 136(2):136-40. PubMed ID: 26457439
[TBL] [Abstract][Full Text] [Related]
8. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process.
Akimoto R; Pawankar R; Yagi T; Baba S
ORL J Otorhinolaryngol Relat Spec; 2000; 62(5):257-65. PubMed ID: 10965261
[TBL] [Abstract][Full Text] [Related]
9. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
Lee RJ; Sidey C; Narula AA; James RF
Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
[TBL] [Abstract][Full Text] [Related]
10. Bone destruction mechanisms in chronic otitis media with cholesteatoma: specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1 alpha.
Kurihara A; Toshima M; Yuasa R; Takasaka T
Ann Otol Rhinol Laryngol; 1991 Dec; 100(12):989-98. PubMed ID: 1746847
[TBL] [Abstract][Full Text] [Related]
11. Bone resorption in chronic otitis media: the role of the osteoclast.
Jung JY; Chole RA
ORL J Otorhinolaryngol Relat Spec; 2002; 64(2):95-107. PubMed ID: 12021500
[TBL] [Abstract][Full Text] [Related]
12. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
[TBL] [Abstract][Full Text] [Related]
13. Involvement of interleukin-1 in middle ear cholesteatoma.
Shiwa M; Kojima H; Kamide Y; Moriyama H
Am J Otolaryngol; 1995; 16(5):319-24. PubMed ID: 7503375
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin L activity and its inhibitor in human otitis media.
Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
[TBL] [Abstract][Full Text] [Related]
15. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
Sanković-Babić S; Sofronić-Milosavljević Lj
Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
[TBL] [Abstract][Full Text] [Related]
16. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
Li Z; Li X; Liu G
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
[TBL] [Abstract][Full Text] [Related]
17. Localization of cytokines in cholesteatoma tissue.
Marenda SA; Aufdemorte TB
Otolaryngol Head Neck Surg; 1995 Mar; 112(3):359-68. PubMed ID: 7532849
[TBL] [Abstract][Full Text] [Related]
18. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
[TBL] [Abstract][Full Text] [Related]
19. Keratinocyte growth factor and its receptor expression in chronic otitis media with and without cholesteatoma.
Harabagiu OE; Cosgarea M; Mogoantă CA; Leucuţa DC; Maniu AA
Rom J Morphol Embryol; 2017; 58(4):1333-1338. PubMed ID: 29556625
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen in chronic otitis media: an immunohistochemical study of the middle ear mucosa.
Sankovic S; Sofronic L
Acta Otorhinolaryngol Belg; 2002; 56(1):61-4. PubMed ID: 11894632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
